Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

Takeda Canada Inc., the Canadian arm of Japan's Takeda Pharmaceutical Co. Ltd. (TAK) on Wednesday entered into a contract with Canadian Blood Services (CBS) for GLASSIA (alpha-1 proteinase inhibitor) resulting from CBS's request for proposal for hereditary deficiency of Alpha-1 Antitrypsin Deficiency (Alpha-1).

RTTNews | 596天前

Takeda Says Japan Approves CUVITRU Subcutaneous Immunoglobulin For Patients With Agammaglobulinemia

Takeda Pharmaceutical Co. Ltd. (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] in patients aged 2 years and older with agammaglobulinemia or hypogammaglobulinemia disorders.

RTTNews | 682天前

Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD) after induction therapy with ENTYVIO intravenous (IV).

RTTNews | 694天前

Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis

Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.

RTTNews | 696天前

Australian Market Trims Early Losses In Mid-market

The Australian stock market is trimming its early losses in mid-market moves on Friday, extending the slight losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in financial and technology stocks partially offset by gains in mining stocks.

RTTNews | 1小时9分钟前

Asian Markets Mixed Amid Tariff Caution

Asian stock markets are trading mixed on Friday, following the mixed cues from Wall Street overnight, as uncertainty continues over US reciprocal tariffs despite the tariff's kicking in on Thursday. Market uncertainty is created by the pressure tactics exerted by the US by constantly altering tariffs. Asian markets ended mostly higher on Thursday.

RTTNews | 1小时12分钟前

Sensex, Nifty Set To Open Lower On Trade Concerns

Indian shares look set to open on a sluggish note Friday as U.S. President has ruled out any possibility of trade negotiations with India and Prime Minister Narendra Modi said India would not compromise on the interests of its farmers, fishermen or livestock rearers, even if it meant paying "a heavy personal price."

RTTNews | 1小时55分钟前

Thai Stock Market May Spin Its Wheels On Friday

The Thai stock market has moved higher in four straight sessions, gathering almost 50 points or 4.1 percent along the way. The Stock Exchange of Thailand now sits just above the 1,265-point plateau although it may be stuck in neutral on Friday.

RTTNews | 2小时28分钟前

EURUSD	1.16594	GBPUSD	1.34367	AUDUSD	0.65221
USDJPY	147.164	USDCAD	1.37394	USDCHF	0.80668

Advertisement

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis